2015
DOI: 10.1016/j.jbiotec.2015.02.018
|View full text |Cite
|
Sign up to set email alerts
|

In vitro production and antifungal activity of peptide ABP-dHC-cecropin A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…Fermentation was performed as described previously [26], ABP-dHC-cecropin A were done as described previously [15].…”
Section: Large-scale Recombinant Protein Expression By Batch Fermentamentioning
confidence: 99%
See 1 more Smart Citation
“…Fermentation was performed as described previously [26], ABP-dHC-cecropin A were done as described previously [15].…”
Section: Large-scale Recombinant Protein Expression By Batch Fermentamentioning
confidence: 99%
“…The antibacterial activity curves of ABP-dHC-cecropin A are shown in Figure 6B; 0. to proteolytic degradation, and low production yield. In our previous work, we used a monomer ABP-dHC-cecropin A SUMO fusion protein for expression [15]. Although the fusion protein was soluble, the quantity produced was not very large.…”
Section: Antimicrobial Activity Assaymentioning
confidence: 99%
“…E. coli expression systems have been extensively demonstrated to effectively produce AMPs, but the AMP must be fused to a carrier protein in order to protect the bacterium from antimicrobial activity (Li, 2009). Various fusion partners have been used, such as SUMO (Li et al , 2009a; Zhang et al , 2015), GST (Liang et al , 2006) and TRX (Tian et al , 2009), but these must be removed post-production to restore antimicrobial activity to the AMP, adding an extra cost to production. A variety of ingenious methods have been proposed to perform the cleavage event without the use of proteases post-production (Tian et al , 2009; Ke et al , 2012), but, with one exception (Rothan et al , 2014), AMPs that retain antimicrobial activity while still bound to the fusion partner have not been produced in bacteria.…”
Section: Introductionmentioning
confidence: 99%
“…To conquer the difficulty of host self-destruction by the toxic target peptides, the fusion protein method was proposed to reduce the toxicity. This method has been used for many peptides expression, including thioredoxin [10], green fluorescent protein (GFP) [14], small ubiquitin-related modifier (SUMO) [15], and cationic elastin-like polypeptides (CELP) [16]. In this study, intein (INT) was used as the fusion peptide to reduce the toxicity of the antibacterial cecropin B2.…”
Section: Introductionmentioning
confidence: 99%